|
595 Over-the-counter
simvastatin given the go-ahead Simvastatin will become a pharmacy
medicine this summer, it was announced on 12 May ...more
595 Guild
issues second warning on pay reform implementation Hospital
pharmacists working in the NHS should not allow themselves to be pressured
into agreeing to inaccurate new job descriptions under pay reform plans,
the Guild of Healthcare Pharmacists has advised ...more
595 Transitional
model for contract in Scotland A transitional model of funding
before full implementation of the new contract for community pharmacists
in Scotland is being drawn up ...more
595 High
Court case next week The Society's application for summary
judgment in the Charter petition case will be heard in the High Court
on Tuesday 18 May ...more
596 New
patient guide on medication review launched “Focus on your medicines” — a guide to medicines reviews for patients — has been launched by the Medicines Partnership
...more
596 People
cautious about internet information Most people are cautious
about the dangers of using health information gleaned from the internet,
according to researchers from the University of York ...more
596 Women
returning to HRT for symptom control Up to a fifth of women
who stopped hormone replacement therapy in the past 18 months have resumed
their treatment, a survey of 400 women has revealed ...more
596 DTB
online A web-based version of Drug and Therapeutics Bulletin and Treatment
Notes has been launched online ...more
596 NHS
information revolution A new Department of Health website
for health professionals has been launched that shows current and planned
health promotion messages aimed at the public ...more
597 NPA
to reflect community pharmacy more widely Previously excluded pharmacy owners are to be allowed to become members of the National Pharmaceutical Association in order to strengthen the association’s claim to represent community pharmacy fully
...more
597 UKCPA
launches emergency care group Pharmacists can contribute to
keeping patients out of hospital and preventing inappropriate admissions,
Nicola Wake, lead pharmacist, medicine, told delegates at the launch
of the UKCPA emergency care practice interest group. The launch took
place at the UK Clinical Pharmacy Association spring symposium held in
Birmingham last weekend ...more
597 Two
more medicines advertisements blocked by regulator Promotional
material for two anti-hypertensive agents has been withdrawn after complaints
to the Medicines and Healthcare products Regulatory Agency ...more
597 Interact
online Counter assistants who work for National Pharmaceutical
Association member pharmacies will be able to complete their NPA Interact
training assessments online from June ...more
597 UniChem
launches financial support service UniChem is launching a
new financial assistance programme for pharmacists. The programme will
offer
guidance on investment, purchase and acquisition, and is being operated
in partnership with NatWest ...more
597 Moss
weight management Moss Pharmacy has launched a free weight management service as part of its “At the heart of your health” campaign
...more
|
598 World Health
Organization report focuses on AIDS Delivery of treatments
for AIDS and the implementation of disease prevention initiatives will
help strengthen health systems in the world's poorest countries, providing
long-term health benefits for everyone, according to a new report from
the World Health Organization ...more
598 Nottingham
university pharmacy student is “Graduate of the year” Pharmacy
student Conall Watson has won the title “Graduate of the year 2004” ...more
598 Woeful lack
of evidence for gout treatments, says DTB There is
a “woeful” lack of evidence to guide treatment or prophylaxis
for gout, particularly with regard to choice of drug or doses, according
to the latest issue of Drug and Therapeutics Bulletin ...more
599 New therapeutic
option for advanced breast cancer Post-menopausal women with
advanced breast cancer that has recurred or progressed have another treatment
option with the launch of a new drug this week ...more
599 Cisplatin
of benefit in head and neck cancer Cisplatin, given with postoperative
radiotherapy, improves disease-free survival in cancer of the head and
neck. Two phase III trials with this finding were published last week — one
carried out by a US group and the other by European researchers ...more
599 Scotland
rejects temoporfin for head and neck cancer Temoporfin (Foscan)
is not recommended for use within NHS Scotland for palliative treatment
of patients with advanced head and neck cancer, says the Scottish Medicines
Consortium ...more
599 Botox for
enlarged prostate Injections of botulinum toxin A (Botox)
into the prostate may offer an alternative treatment for men with benign
prostatic hyperplasia, say researchers ...more
599 Homoeopathy
trial in pharmacies An observational study funded by the NHS
in Glasgow has been launched to investigate the feasibility of using
homoeopathic medicines to assist in smoking cessation ...more
599 Affluence
and heart failure People who live in socioeconomically deprived
areas are more likely to develop heart failure but less likely to see
their GP regularly, research conducted in Scotland has shown. By contrast,
prescribing patterns did not vary according to the socioeconomic status
of patients ...more
600 First candidates
gain new NVQ certificates in pharmacy services Two pharmacy
team members became the first in the UK to complete a new National Vocational
Qualification level 2 in pharmacy services last week ...more
600 Section 60
consultation begins for opticians Plans for reform of the
General Optical Council (GOC) and changes to the laws governing registration
to practise as an optometrist or dispensing optician have been published
by the Department of Health ...more
600 Supplementary
prescribing to be extended next year Chiropodists, physiotherapists,
radiographers and optometrists are to be the next professionals to join
the ranks of supplementary prescribers. The planned legislative change
will apply throughout the UK, but it is for the devolved administrations
to determine the extent of its local application in the NHS ...more
|
The
Pharmaceutical Journal